Julia Djonova

Company: Swissmedic

Job title: Head Division ATMP

Seminars:

Panel Discussion – A European Industry & Regulatory Perspective on the Development & Approval of mRNA Medicines 5:30 pm

Uncovering how regulatory provisions can support mRNA medicines’ approval Reducing the regulatory approval timeline through platform technology approaches Moving towards a harmonized approach for mRNA medicines for the benefit of patientsRead more

day: Day 1 PM

Swiss Regulatory Aspects & Evaluation for mRNABased Vaccines & Therapeutic Pathways to Approval 12:15 pm

Exploring harmonisation regulatory challenges and expectations for new mRNA drugs applications and documentation Delineating the mRNA platform definition for vaccine, therapeutic and broader applications Highlighting regulatory progress in personalised mRNA cancer vaccines and manufacturing considerationsRead more

day: Day 1 Track 2 AM